Device Authority targets a core security gap in healthcare

Tern plc

Legacy medical devices are not disappearing from healthcare networks. Many hospitals still depend on older equipment that remains clinically useful, expensive to replace and difficult to take offline. That reality creates a clear security challenge: connected medical devices need to be protected even when they were not designed for today’s cybersecurity demands.

Device Authority argues that healthcare organisations need an identity-first security strategy to manage this risk. It is not enough to know that a device is connected to a network. Healthcare providers need to know what the device is, whether it can be trusted, whether its credentials are valid and whether it should be allowed to communicate with other systems.

Many legacy medical devices were built before modern security standards became common. Some may lack strong authentication. Others may rely on outdated software, limited update options or weak certificate management. In a hospital setting, these weaknesses can be difficult to fix quickly because the devices may support critical services and cannot always be replaced or patched without affecting clinical operations.

An identity-first approach puts the device itself at the centre of the security model. Each device needs a trusted identity that can be issued, managed, renewed and revoked across its lifecycle. This makes it easier to control access, reduce exposure and support compliance without depending only on network-based defences. It also gives healthcare organisations a more practical way to manage risk across mixed estates of new and old devices.

For Device Authority, the message is commercially relevant. Healthcare is a sector where connected-device security is not optional, but replacement cycles are long and operational disruption carries real consequences.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Search